HER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract Cancer

2 clinical trials · Condition

Record	Firm	Date
First-line Trastuzumab, Gemcitabine, Cisplatin and Nivolumab in Advanced HER2- Positive Biliary Tract Cancer: a Multicenter, Open-label, Single-arm Phase Ib/II Trial (HERBOT) (NCT05749900)	Yonsei University	2023-05-12
Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy (NCT04722133)	Yonsei University	2020-06-23

Every clearance here is in the API, with alerts when new ones post.